Looking for clear information on lung biopsy cost in Hyderabad? A lung biopsy samples a nodule, mass or lymph node in the chest so a pathologist can confirm what it is — and, if it is cancer, provide tissue for the molecular tests that guide modern treatment. It can be done as a CT-guided needle biopsy through the chest wall, through a bronchoscope (including EBUS), or surgically. At CION Cancer Clinics, CT-guided needle biopsy is performed by a specialist, while bronchoscopic/EBUS and surgical biopsies are arranged through a partner — and every case is reviewed by a tumour board. Your first consultation is free.
Starting from ₹13,000
There is no single price for a lung biopsy — it depends mainly on the method and the laboratory and molecular testing. The table below lists the common approaches. Your exact, confirmed price is shared once your scans and reports are reviewed. Histopathology and any special tests (such as IHC, molecular testing or flow cytometry) are charged separately — see below.
| Lung biopsy method | Starting price |
|---|---|
| CT-guided (transthoracic) needle biopsy | ₹13,000 |
| Bronchoscopic biopsy / EBUS-TBNA | By partner referral |
| Surgical (VATS) lung biopsy | Specialised — quote on review |
Prices shown are indicative and may vary by site, image guidance and the pathology testing required. Histopathology and any special tests (IHC / molecular) are charged separately unless stated.
A lung biopsy is usually advised when a CT scan shows a suspicious nodule or mass, or enlarged lymph nodes in the centre of the chest. The method is chosen to reach the lesion most safely — peripheral lesions are usually sampled through the chest wall under CT guidance, while central lesions and lymph nodes are reached through a bronchoscope. Importantly, the tissue obtained can be tested for molecular changes that direct targeted treatment.
This page sits within our wider Biopsy Cost in Hyderabad guide. CION Cancer Clinics performs and coordinates biopsies across centres in Hyderabad, supported by a wider network of 35+ partner centres across Telangana and Andhra Pradesh — so your sample is taken by a cancer specialist and reviewed by a tumour board.
A lung biopsy does more than confirm cancer — it provides tissue for molecular and biomarker tests that guide targeted therapy and immunotherapy. As the U.S. National Cancer Institute notes, this testing is now central to planning lung-cancer treatment.
For a nodule near the edge of the lung, CT guides a fine needle through the chest wall to take a sample. It is the usual choice for peripheral lesions. See our pages on CT-guided biopsy and image-guided biopsy.
A thin flexible scope passed through the airway samples central lesions; with endobronchial ultrasound (EBUS), lymph nodes beside the airways can be sampled with a needle (TBNA) — useful for both diagnosis and staging. This is a form of endoscopic biopsy. CION does not perform bronchoscopy/EBUS in-house; we coordinate it for you through a partner facility and review the results.
If less invasive methods do not give an answer, a keyhole surgical biopsy (VATS) may be used.
As a rule: peripheral nodules are sampled by CT-guided needle biopsy; central lesions and mediastinal lymph nodes by bronchoscopy or EBUS; and a surgical biopsy is kept for cases that remain unclear. Your doctor chooses based on where the lesion is and how safely it can be reached.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Bring your CT scan, prescription or report. Our oncologists explain which biopsy is safest for your lesion — and you're welcome to a free written second opinion before you commit to anything.
The main specific risk of a CT-guided lung biopsy is a pneumothorax — a partial collapse of the lung when air leaks into the space around it. It is watched for with a chest X-ray afterwards, is often small and settles on its own, and occasionally needs a small tube to drain the air. Some coughing of a little blood can occur and usually settles. Image guidance and an experienced team keep these risks low.
Your scans and clotting are reviewed beforehand, and you may be asked to pause blood thinners or anticoagulants, only as directed by your doctor. The biopsy is done under local anaesthetic (bronchoscopy often with sedation), and you are observed afterwards, usually with a chest X-ray, before going home.
A histopathology report usually takes about 3–7 working days; molecular and biomarker tests take longer. At CION, the result is reviewed by a tumour board and explained to you with the next step, and you are welcome to a free written second opinion on an outside report.
A biopsy confirms whether a lung lesion is cancer and identifies its type, and the tissue is tested for molecular markers that guide targeted therapy and immunotherapy. Where a tissue biopsy is difficult, a blood-based liquid biopsy (including EGFR testing) may complement it in selected situations. For peripheral nodules, a CT-guided biopsy is the usual route.
For costs, techniques and related concerns, these guides go deeper:
This page is for general information only and is not a substitute for professional medical advice, diagnosis or treatment. Biopsy prices shown are indicative and may vary by type, site, image guidance and the pathology testing required — histopathology and any special tests (such as IHC or molecular testing) are usually charged separately. Always follow the advice of a qualified doctor regarding whether a biopsy is needed and how to interpret the results.
Hear from the patients and families who came to CION for diagnosis, biopsy and cancer care — in their own words.
It depends on the method - CT-guided needle, bronchoscopic/EBUS, or surgical - and the laboratory and molecular testing, which is separate. CION shares an indicative cost once your scans are reviewed, and the first consultation is free.
CT-guided needle biopsy samples peripheral nodules through the chest wall; bronchoscopy and EBUS reach central lesions and lymph nodes through the airway; a surgical (VATS) biopsy is used if these do not give an answer. Your doctor chooses based on the lesion’s location.
A CT-guided biopsy is done under local anaesthetic, so you feel pressure rather than sharp pain; bronchoscopy is usually done with sedation. You are observed afterwards before going home.
A CT-guided lung biopsy can cause a pneumothorax (partial lung collapse). It is checked for with a chest X-ray, is often small and settles on its own, and occasionally needs a small tube to drain the air. The risk is kept low with image guidance and an experienced team.
Because the tissue can be tested for molecular changes that guide targeted therapy and immunotherapy. This testing is now central to planning lung-cancer treatment.
A histopathology report usually takes about 3-7 working days; molecular and biomarker tests take longer. Results are reviewed by a tumour board and explained with the next step.
Yes - it confirms whether a lung lesion is cancer and identifies its type. A scan can find a nodule but cannot tell whether it is benign or malignant.